In genome-wide association studies (GWAS), hundreds of thousands of genetic features (genes, proteins, etc.) in a given case-control population are tested in favor of the null hypothesis that there is no association between each genetic marker and a specific disease. A popular approach in this regard is to estimate local false discovery rate (LFDR), the posterior probability that the null hypothesis is true, given an observed test statistic. Assuming a certain structure for the underlying model, covering many situations in genome-wide association studies, we use the method of moments and introduce a simple, fast and efficient method for LFDR estimation.
INTRODUCTION
Genetic association studies deal with investigating an association between some disease traits and some genetic features, including genes, proteins, lipids and single nucleotide polymorphisms (SNPs). The investigation follows certain strategies to determine whether there exists some kind of statistical association. In case-control studies, the investigation is started by the determination of differences between the frequency of alleles or genotypes at genetic marker loci in individuals from a given population. Significant differences then reflect strong statistical evidence to claim for existence of association. In this paper, we focus on the analysis of genetic SNP data from population-based genome-wide association studies (GWAS). However, one may apply the results to other data sets, as long as the underlying model follows the structure considered in this paper.
In GWAS, SNPs (with being usually hundreds of thousands) are genotyped in a given case-control population, and are tested in favor of the null hypothesis 0 , = 1, … , , that there is no association between SNP and the disease, and against the alternative hypothesis 1 that there is such an association in that population. For an individual SNP , the classic statistics deals with testing 0 versus 1 by verifying whether a test statistic falls inside some critical region  , where is the significance arXiv:1909.13307v2 [stat.AP] 3 Oct 2019 level (type-I error or false positive rate). As an example, if represents an estimated allelic odds ratio (OR) for SNP , then a critical region may be presented by  = { ∶ < 2 1;1− ∕2 or > 2 1; ∕2 }, where 2 1;1− denotes 100(1 − )%-quantile of the chi-square distribution with one degree of freedom. Alternatively, the single hypothesis problem might be tested by comparing the significance level with the resulting p-value , the smallest value of such that ∈  . According to Fisher's scale of evidence for interpreting p-values, the less p-value, the more evidence against the null hypothesis 0 1 . Either way, the procedure is simple and convenient to use, but the approach leads to a high-rate of false discoveries. To overcome this challenging situation, several improvements on a set of given p-values have been introduced in the literature, see 2,3 , 4 , 5 and 6 . Alternative to p-value adjustment procedures, is the false discovery rate (FDR) estimation introduced by Benjamini and Hochberg 7 , aiming at controlling the expected proportion of falsely rejected hypotheses. This seminal work led to many developments. For example, Storey 8 develops a Bayesian approach for estimating FDR and Efron et. al 9 outline an empirical Bayesian interpretation. The latter defines FDR as the posterior probability that a null hypothesis 0 is true given that an observed test statistic falls within some critical region , i.e., ( 0 is true|). In case the critical region  consists of only one point, FDR is referred to by the term Local FDR (LFDR), see Efron 1 and Padilla and Bickel 10 .
In the problem of testing SNPs against the null hypothesis 0 , = 1, … , , we assume that each of the SNPs is unassociated (with some disease) with prior probability 0 . We further suppose that the test statistic follows a null density, say 0 , with chance 0 and a non-null density, say 1 , with chance 1 = 1 − 0 . Then, LFDR for each SNP is defined as follows
where ( ) = 0 0 ( ) + 1 1 ( ). In general 0 is assumed to be known (e.g., standard normal density, central chi-square density with some known degree(s) of freedom, etc.), 1 is assumed to be a known density function with some unknown parameter(s) (e.g., normal density with unknown mean and/or unknown variance, chi-square density with some known/unknown degree(s) of freedom with some unknown non-centrality parameter, etc.), and 0 is an unknown parameter. Such unknown parameters need to be estimated before making any inferences. Estimated values are then replaced in equation (1) and the resulting estimated LFDR, saŷ , is compared to some pre-determined threshold. SNPs not passing the pre-specified threshold are deemed to be associated with the underlying disease. Different strategies have been used for LFDR estimation in the literature. Pan et al. 11 and Efron 12 , 13 perform the estimation task using a discrete mixture model, and Muralidharan 14 , Padilla and Bickel 10 and Yang et al. 15 use the maximum likelihood (ML) approach. Bickel 16 summarizes strengths and weakness of classic and empirical Bayes estimation approaches.
In this paper, we assume a certain structure for the underlying model. We assume a multiple hypothesis testing problem in which SNPs in a given case-control population are tested in favor of the null hypothesis 0 , = 1, … , , that there is no association between SNP and a certain disease. We assume that 0 , the true proportion of unassociated SNPs, is unknown. Further, we assume that 0 represents a central chi-square density function with some known degree(s) of freedom . We also assume that 1 represents a non-central chi-square density function with degree(s) of freedom and an unknown non-centrality parameter . We will discuss in the forthcoming section that these assumptions are not restrictive and are made in many genetic association studies.
Being concentrated on the chi-square model, Padilla and Bickel 10 as well as Karimnezhad and Bickel 17 assume that the test statistics , = 1, … , , are independent and estimate the corresponding LFDR by using the ML approach, i.e.,
where
in which and are known bounds. Although this approach leads to somehow sensible estimators, the independency assumption might be unrealistic in genetic association studies due to linkage disequilibrium (LD). Also, the resulting LFDR estimates highly depend on the bounds of and , and inappropriate choices for these bounds can negatively affect the estimation precision. As another downside, this estimation procedure is time-consuming, and the processing time increases with the number of SNPs as well as the length on the interval [ , ] . Alternative to this approach, we provide a simple yet efficient algorithm that estimates LFDRs without assuming independency. We theoretically show that the resulting estimator has a high precision as long as , the number of SNPs to be tested, is large. Not only is the proposed approach fast, but also it provides an explicit form of estimators of the proportion rate 0 and the non-centrality parameter . As a result, unlike many algorithms including the ML approach of Padilla and Bickel 10 and the histogram-based (HB) approach of Efron 1 , it provides an explicit form of the corresponding LFDR estimator. The structure of this paper is as follows. In Section 2, we quickly review frequent measures for genetic association studies used in the literature. We discuss that many genetic association studies reduce to a multiple hypothesis testing problem in a chisquare model. In Section 3, we present our proposed empirical Bayes approach. Section 4 is devoted to evaluating performance of the proposed approach. We follow two different simulation strategies and use the mean squared error (MSE) as a common measure of performance. In Section 5, we apply the proposed approach and analyze two different sets of real data, including a set of microarray data and another set of coronary artery disease data. We wrap up the paper by providing some discussion and concluding remarks in Section 6.
COMMON MEASURES FOR ASSOCIATION
Consider a diallelic marker locus with a typical allele (wild-type) and the alternative (risk) allele , and let represent the frequency of the risk allele, i.e., = ( ) and 1 − = ( ). Denote the corresponding genotypes by 0 = , 1 = and 2 = (we do not distinguish between and ). Then, genotype frequencies in the population are given by = ( ), = 0, 1, 2, where 0 = (1 − ) 2 + (1 − ) , 1 = 2 (1 − )(1 − ) and 2 = 2 + (1 − ) , in which is Wright's coefficient of inbreeding. For humans, is usually taken to be between 0 and 0.05. Under Hardy-Weinberg (HW) equilibrium, = 0. Thus, when HW proportions hold in the population, 0 = (1 − ) 2 , 1 = 2 (1 − ) and 2 = 2 . Let the prevalence of the disease be = ( ), and define = ( | ), the probability of having a disease given a specific genotype at the marker for genotype , = 0, 1, 2. Obviously, = ∑ 2
=0
. Depending on a chosen genetic model, the penetrances have certain relationships with themselves. If the genetic model is additive, then 1 = 0 + 2 2 . For recessive, multiplicative and dominant models, 1 = 0 , 1 = √ 0 2 and 1 = 2 , respectively, see Zheng et al. 20 . Genetic association is usually measured for each individual SNP separately. The data for each SNP can be summarized in a contingency table of either genotype counts or allele counts by disease status (case or control). Table 1 represents genotype counts at marker based on a sample of cases and controls. Intuitively, the chance of observing genotype provided that an individual is known to belong to the case group is estimated by , which is in fact the ML estimate of = ( | ). Similarly, = ( | ) is the true chance of having genotype for a control individual which, with the notations in Table 1 , is estimated by . It is easy to verify using the Bayes principle that = and = (1− ) 1−
. Table 2 represents allele counts at marker based on a sample of cases and controls. Contingency tables play a key role in summarizing genetic association data. Under the null hypothesis that there is no association between genotypes in Table 1 (or alleles in Table 2 ) and the disease, the same relative genotype (or allele) frequencies in both case and control groups are expected. Contingency tables also allow to summarize data using different models of penetrance. Perhaps Pearson's test is the most convenient association test in contingency tables. Pearson's test statistic for the genotypes in Table 1 can be presented by
which approximately follows a chi-square distribution with two degrees of freedom. In the same way, the test can be applied to allele counts in Table 2 , and the resulting test statistic approximately follows a chi-square distribution with one degree of freedom, see Zheng et al. 20 and Clarke et al. 21 among many others. In fact, any test statistic in genetic association studies by means of a contingency table follows a chi-square distribution with at most two degrees of freedom, see Table 2 of Clarke et al. 21 . Readers may also refer to Clarke et al. 21 for a summary of strengths and weaknesses of allelic and genotypic tests of association, as well as the differences between the different models of penetrance.
As an alternative association test, Cochran-Armitage trend (CAT) test is used in situations where some kind of trend in risk of developing the disease with increasing number of the risk allele in three genotypes is determined. The CAT test assigns some scores 1 , 2 and 3 to the three genotypes 0 , 1 and 2 with the condition that 0 ≤ 1 ≤ 2 and 0 < 2 , and looks for weighted differences between the genotype frequencies in cases and in the union of case and control samples. The corresponding test statistic is given by
, which under the null hypothesis of no association follows a chi-sqaure distribution with one degree of freedom. The weights 0 , Odds ratios (ORs) are another common measure of association between genotypes and diseases. ORs compare the odds of disease in an individual carrying one genotype to the odds of disease in an individual carrying a different genotype. Thus, for a diallelic marker, the following two genotypic ORs can be defined
1 compares the odds of disease between individuals carrying genotype and those carrying , and 2 compares the odds of disease between individuals carrying genotype and those carrying . In case of no association, 1 = 2 = 1. According to the data in Table 1 , ORs can be estimated bŷ = 0 0 witĥ (̂ ) = 1 0
or equivalently 2 ∼ 2 1 . An OR can also be defined to the allele counts in Table 2 . If so, an estimated OR is given bŷ = (2 0 + 1 )(2 2 + 1 )
Similarly, the corresponding test statistic follows a chi-square distribution with one degree of freedom. A more flexible analysis for GWAS is based on the logistic regression model. Let the binary random variable represent whether ith individual belongs to the case group ( = 1) or to the control group ( = 0), and let denote the genotype of individual for an arbitrary SNP so that ( 0 ) = 0, ( 1 ) = 1 and ( 2 ) = 2. Then, the logistic model is defined as ln
is the expected value of phenotype given a genotype for an arbitrary SNP. With this setting, the multiple hypothesis testing problem reduces to testing 0 ∶ 1 = 0 vs 1 ∶ 1 ≠ 0, = 1, … , . The corresponding test statistic is computed by
. Under the null hypothesis of no association, it follows that ∼ (0, 1) or equivalently 2 ∼ 2 1 . For details see Padilla and Bickel 10 , Yang et al. 15 and Karimnezhad and Bickel 17 .
A NOVEL EMPIRICAL BAYESIAN METHOD
As discussed in the preceding section, many genetic association studies reduce to a multiple hypothesis testing problem in which the corresponding test statistics follow a chi-square distribution. To conduct such a hypothesis testing problem, we propose to apply and estimate LFDRs by using a simple and efficient empirical Bayes approach, as we present below.
Suppose that SNPs have been genotyped in a case-control population, and that the goal is to test the null hypothesis 0 , = 1, … , , indicating that there is no association between SNP and the disease, against its alternative hypothesis 1 . Suppose that for each SNP , the test statistic has already been computed using any of the approaches reviewed in the preceding section. Then, let an indicator variable represent whether th null hypothesis is true in nature, i.e., 0 ∶ = 0 and 1 ∶ = 1. Further, let 0 ∈ [0, 1] be the true proportion of SNPs not associated with the disease, and define = 0 with probability 0 , 1 with probability 1 − 0 .
In fact, this indicator variable assigns some chance 0 to each null hypothesis to be true. Define to be a two-state variable so that it takes 0 if = 0, and takes a positive value if = 1. Further, assume that the test statistic follows 2 , , the chisquare distribution with degree(s) of freedom and non-centrality parameter . This model can be expressed by the following hierarchical model
Such a hierarchical Bayes model has already been applied in detecting variants in the analysis of next generation sequencing data 22 .
As we reviewed earlier, the degree(s) of freedom in many genetic association studies reduces to one. Concentration on the chi-square distribution with one degree of freedom leads to the following nice simplification in LFDR estimation. Theorem 1. Let , = 1, … , , follow the chi-square distribution with one degree of freedom and the non-centrality parameter parameter .
(i) The density function of an observation can be expressed by
(ii) Let be an observation from the mixture density ( ) = 0 0 ( ) + (1 − 0 ) ( ). Then, the LFDR based on observing is given by
and for a given threshold , ( ) < if and only if > ℎ ( 0 , ), where
with ( 0 , ) = 0 2
Proof. The proof is straightforward and hence omitted.
Equation (7) is in fact a simplified version of equation (1) applicable to genetic association studies. In order to be able to estimate the LFDR, the parameters 0 and in (7) need to be estimated. In this regard, we propose estimating the LFDR using the method of moment (MM) estimation, which suggests that unknown parameters in a model should be estimated by matching theoretical moments with the appropriate sample moments 23 . Theorem 2. With the setting of Theorem 1, let 1 = 1 ∑ and 2 = 1 ∑ 2 represent the first and the second moments, respectively. Then, MM estimators of and 0 are given bŷ
Proof. By using the properties of conditional expectation, observe that
and
. Now, using that fact that [ | = 1] = and [ 2 | = 1] = , along with equating the above expectations with the first and second moments, the above equations lead to (9) .
Consistency of the MM estimators 23 guarantees that̂ and̂ 0 converge in probability to and 0 , respectively. We show in the next section that̂ and̂ 0 estimate the true parameters and 0 very well.
To make an inference regarding association between th SNP and the disease, one may compute the estimated LFDR̂ by replacing estimates of and 0 from equation (9) into equation (7) . Therefore, if for a given threshold ,̂ < , the null hypothesis 0 is rejected. Otherwise, there is no evidence of association. An alternative approach would be to replace estimates of and 0 from equation (9) into ℎ ( 0 , ) in equation (8) . Then, 0 is rejected only if the test statistic is less than ℎ (̂ 0 ,̂ ). The second approach is simpler and more convenient, and unlike the existing methods in the literature, it allows for performing multiple hypothesis testing by just comparing each of the test statistics with a purely data-based threshold. i.e., ℎ (̂ 0 ,̂ ).
The threshold in (8) can be chosen according to a subjective belief. A conventional choice would be to choose = 0.2 to identifying "interesting cases", see Efron 1 . It also can be chosen based on an objective belief. In this regard, Karimnezhad and Bickel 17 follow a decision theoretic approach in which for a binary decision rule , the null hypothesis 0 is rejected if = 1, and is not rejected if = 0. They used the following loss function where and are loss values incurred due to making type I and type II errors, respectively. The resulting Bayes estimator of the parameter is then given by
Now, it can be verified using Theorem 1 that the Bayes rule in equation (10) reduces to the following Bayes rule
with = + . This Bayes rule is simpler and more convenient than the Bayes rule in equation (10), due to the fact that it is based on the observed test statistic and estimates of 0 and , which are available through the equation (9) . In fact, equation (11) illustrates that, unlike many existing algorithms in the literature, one may perform a multiple hypothesis testing comparison by just comparing their observed test statistics and the data-based function ℎ (̂ 0 ,̂ ).
SIMULATION
To illustrate the performance of the proposed LFDR estimation approach, we conduct simulations using two different strategies.
First simulation study
We follow the simulation strategy used in Karimnezhad and Bickel 17 . We take advantage of the fact that squared of log transformation of OR follows a chi-square distribution with one degree of freedom (see equation (5)), and that as reviewed in Section 2, many algorithms in genetic association studies reduce to a chi-square model with one degree of freedom. For each iteration in our simulation study, we assume there are a total number of SNPs to be tested, of which 0 SNPs are unassociated. We generate from (log( ), 2 )-distribution, where 2 is known, and for = 1, … , 0 , = 1, and for = 0 + 1, … , , ≠ 1. Obviously, = ( ) 2 ∼ 2 1, , where for = 1, … , 0 , = 0, and for = 0 , … , , = log( ). We take the steps in Algorithm 1.
We carried out different simulations with different parameters. Figures 1a-1b reflect the simulation results based on taking 0 = 250, 500, 1000(1000)9000, 9500, 9750, = 10000, = 100 and = 1.25, 1.5. Because from (6), variance of OR is expected to be a very small number, we took 2 = 0.01, 0.02. By these choices of OR and 2 , the true non-centrality parameter Figure 1a , we observe that for different values of 0 (especially when 0 ≥ 0.80),̂ 0 estimates the true 0 very well. Remarkably, as the true 0 increases, MSE of the corresonding MM estimator decreases. As well, it is evident from Figure 1b that for different values of 0 ,̂ estimates the true non-centrality parameter quite well. Although for high values of 0 ,̂ yields to an increase in ,̂ 0 leads to a decrease in 0 . However, the MM estimated values of 0 and lead to very low values, as presented in Figure 2 . Also, as observed from this figure, a decrease in 2 or an increase in OR leads to a decreased MSE.
Algorithm 1 First simulation strategy.
Step 1. Specify , 0 , and 2 .
Step 2. Take = 1.
Step 3. Generate 1 , … , 0 from (0, 2 )-distribution.
Step 4. Generate 0 +1 , … , from (log( ), 2 )-distribution.
Step 5. Compute = ( ) 2 , = 1, … , , the chi-square test statistics.
Step 6. Computê 0 and̂ using equation (9).
Step 7. Computê 1 , … ,̂ by replacinĝ 0 and̂ into equation (7) .
Step 8. Compute errors in estimating 0 , and by 0 = (̂ 0 − 0 ) 2 , 0 = (̂ − ) 2 and = 1 ∑ =1 (̂ − ) 2 , respectively.
Step 9. Increase by one and repeat Steps 3 to 8 for times. Then, compute 
FIGURE 2
Plots of for different values of 0 in the first simulation strategy.
Second simulation study
We simulate case-control samples for each SNP given an additive model. The simulation strategy follows the steps in Algorithm 2. Although this simulation strategy includes more parameters than the first one, it does not allow to control the true parameter . The only true parameter which is known from the beginning of the simulation is 0 = 0 . Thus, in this simulation strategy, we are only able to measure the accuracy in estimating 0 . However, sincê in equation (9) directly depends on the value of̂ 0 , a perfect estimate of̂ 0 would automatically lead to a reliable estimate of . Following the above simulation algorithm, we conducted different simulations with different parameters. We took = 1000, = 1000, = 0.2, 0 = 0.01, 2 = 1.25, 1.5, 2, 0 = 250, 500, 1000(1000)9000, 9500, 9750, = 10000 and = 100. Figure 3 represents the accuracy in estimating 0 . From this figure we observe that the proposed estimator of 0 using the MM approach has a very desirable performance. As discussed above, this convinces that the corresponding non-centrality parameter was also perfectly estimated. Consequently, the resulting LFDR estimates are highly precise and reliable. As observed from Figure 3 , an increase in OR leads to a decreased MSE, as expected. Algorithm 2 Second simulation strategy.
Step 1. Specify the numbers of cases ( ) and controls ( ), the allele frequency for the risk allele and the reference penetrance 0 .
Step 3. Take 2 = 1.
Step 4. Calculate 2 using the following equation
where 0 = log 0 1− 0 and 2 = log( 2 ) (the above equation is in fact the prospective logistic regression model).
Step 5. Calculate 1 = 1 2 ( 0 + 2 ) (this is due to selecting ad additive model).
Step 6. Calculate = ∑ 2
=0
, where 0 = (1 − ) 2 , 1 = 2 (1 − ) and 2 = 2 .
Step 7. For = 1, 2, 3, calculate = ∕ and = (1 − )∕(1 − ).
Step 8. Take = 1.
Step 9. Generate random samples ( 0 , 1 , 2 ) and ( 0 , 1 , 2 ) independently from the multinomial distributions ( ; 0 , 1 , 2 ) and ( ; 0 , 1 , 2 ), respectively. This leads to a 2 × 3 Table similar to Table 1 .
Step 10. Similar to Table 2 , construct the corresponding 2 × 2 Table and compute the chi-square test statistic of independence, i.e., = ∑ 4 =1 ( − ) 2 ∕ , where 1 = 2 0 + 1 , 2 = 1 + 2 2 , 3 = 2 0 + 1 , 4 = 1 + 2 2 , 1 = 2 (2 0 + 1 )∕(2( + )), 2 = 2 ( 1 + 2 2 )∕(2( + )), 3 = 2 (2 0 + 1 )∕(2( + )), 4 = (2 )( 1 + 2 2 )∕(2( + )) with = 0 + 1 + 2 , = 0 + 1 + 2 and = + , = 1, 2, 3.
Step 11.
Step up by one and repeat Steps 9-10 until = 0 .
Step 12. Take 2 = ≠ 1 and repeat Steps 4-7.
Step 13. Increase by one, and repeat Steps 9-10 until = .
Step 14. Estimate 0 and bŷ 0 and̂ using the generated test statistics 1 , … , and equation (9) .
Step 15. Compute the error of estimating the true proportion of unassociated SNPs by 0 = (̂ 0 − 0 ) 2 , where 0 = 0 .
Step 16. Increase by one and repeat Steps 3-15 for times. Then, compute
APPLICATIONS

Application to a microarray data set
In this subsection, we use a prostate data set used by Efron 1 in which genetic expression levels for 6033 genes were obtained for 102 men including 50 normal control individuals and 52 prostate cancer patients. The interest is to test whether there is any difference between gene expression level and the prostate and normal individuals, = 1, … , 6033. Let̄ (1) and̄ (2) be the mean of the normal individuals and cancer patients, and suppose that is an estimate of the pooled sample standard error. To conduct this multiple hypothesis testing problem, the two-sample test statistics =̄ (1) −̄ (2) need to be computed first. One may then convert these test statistics to standard normal statistics = Φ −1 ( 100 ( )) where Φ and 100 are the cumulative distribution functions of normal and distributions, respectively. By this transformation, the null hypothesis can be expressed as 0 ∶ ∼ (0, 1). Now, to apply our proposed estimation method, it suffices to use the transformation = 2 . Then, the multiple hypothesis testing problem reduces to testing 0 ∶ ∼ 2 1 , and the resulting estimator form equation (9) reduces tô 0 = 0.936. According to Efron 1 's HB approach and with the help of locfdr package 24 , 0 is estimated to be equal to 0.932, see 1 , page 71. We also estimated 0 using the ML approach of Padilla and Bickel 10 . In this regard, we took = 0 and = 10 in equation (3), and applied the LFDR.MLE package of Yang et al. 25 . Table 3 represents estimated values of 0 along with processing time on a personal computer (core i7, 3.5 GHz speed with 16 GB of RAM). Remarkably, the difference between estimates of 0 using the HB and MM approaches is ignorable. We also observe that the MM approach is faster than the other approaches. It is almost 92 and 17 times faster than the ML and HB approaches, respectively. 
Application to a comprehensive coronary artery disease data set
In this subsection, we apply the proposed LFDR estimation approach to analyze a comprehensive 1000 genomes-based genomewide association data analyzed by Nikpay et. al 26 . Then, equation (9) with a processing time of 4.385 seconds led tô 0 = 0.9967 and̂ = 21.9274. By these estimates, estimated LFDRs for the 2,213 variants had a maximum of 0.00032. This suggests that there is strong evidence for the association of the 2,213 SNPs with the CAD.
Nikpay et. al 26 report ten new loci containing candidate causal genes newly implicating biological processes in vessel walls. Our analyses revealed that eight of the ten loci lead to estimated LFDRs less than 0.0003, but we are unable to confirm that the remaining two SNPs (rs11830157 and rs12976411) are associated with CAD.
We also applied the HB and ML approaches to analyze the data. The HB approach failed due to model misfit, and the ML approach with = 0 and = 30 in equation (3) led to a very closê 0 (0.996) to the one reported by the MM approach. However, the processing time (445.237 seconds) was 339 times slower than the MM approach.
DISCUSSION AND CONCLUDING REMARKS
In this paper, we investigated estimating LFDRs for genetic association data. By reviewing well-known measures of association in the literature, we showed that many of the currently used measures reduce to a chi-square model with one degree of freedom. We presented a simple LFDR estimation strategy by using the MM estimators of the proportion 0 and non-centrality parameter . The approach, as presented in Theorem 2 as well as Section 5, is simple and fast to apply. Also, as demonstrated by the two simulation strategies in Section 3 and the real data analysis in Section 5, it leads to reliable estimates. On the other hand, the ML approach of Padilla and Bickel 10 highly depends on the bounds of and in (3), is time consuming, and the processing time increases with the number of SNPs as well as the length on the interval [ , ] . The HB approach of Efron 1 also depends on some preset parameters such as the number of breaks in the discretization of the -scores, the degrees of freedom for fitting the estimated density, etc. 25 , and it may fail due to model misfit.
Our proposed parametric method for estimating false discovery rates relies on the assumption that all non-null features have the same non-centrality parameter. This might not seem biologically realistic, but there are important advantages behind such an assumption. This assumption makes the estimation procedure easy and straightforward. Of course, having different noncentrality parameters in the model make it more biologically realistic, but that would rise the issue of interpretability. A single non-centrality parameter in the model is in fact a measure of the detectability of associations 27 . It can also be interpreted as the average deviation of the data distributions of SNPs associated with a disease from the data distribution of those unassociated SNPs 15 . It is also noteworthy that, according to the results presented in Section 5, having a single non-centrality parameter leads to an ideal model performance.
It is remarkable that, our proposed approach is similar to the classic hypothesis testing in the sense that the test statistic is compared to a threshold. However, the threshold in the MM approach is ℎ (̂ 0 ,̂ ), while in the classic hypothesis testing it is just a 100(1 − 2 )% quantile of the underlying distribution. This ideal property provides a more user-friendly estimator of LFDR than the other existing approaches.
It is worth adding that, estimating LFDRs in the literature is usually done by using some algorithms without knowing explicit form of estimators of the underlying parameters. For example, in the ML estimation used by Padilla and Bickel 10 , an algorithm is applied to find arguments that maximize the likelihood function numerically, without providing any closed form of the resulting estimators of the parameter. Such algorithms may also require some unrealistic assumptions such as independency. On the contrary, our proposed approach offers explicit forms of estimators of the parameters 0 and , without imposing any restriction to the model. This leads to user-friendly estimators using the simple Bayes rule provided in equation (11) . All a user needs is the test statistics and estimated values of 0 and .
As discussed in our second real data analysis, the estimated value of 0 using our proposed approach is very close to the one reported in Efron 1 . Obviously, this compliance confirms that the two approaches estimate 0 very well, but this does not mean that the same threshold of estimated LFDR should be used. This is due to the fact that Efron 1 's LFDR estimation is based on the normal model while our proposed approach is on the basis of the chi-square model. Thus, if one is interested in using a 0.20 threshold when using Efron's HB approach, she/he might use a different one (maybe 0.1 or less) when applying our proposed approach.
The estimation procedure presented in this paper can be used for other purposes, too. For example, Karimnezhad and Bickel 17 introduce LFDR estimation in presence of some additional information such as genetic annotations. They use the ML approach of Padilla and Bickel 10 but one may be interested in applying our proposed estimation approach in their reference class problem. If so, new estimators of LFDR will be derived.
